Despite treatment advances, ‘much to improve upon’ in high-risk neuroblastoma
- OPACC
- Jul 13, 2020
- 1 min read
As outcomes for high-risk neuroblastoma improve, refining treatment approaches in order to reduce late-term effects will be key, according to Giselle Sholler, MD.
Comentários